Nasser Samadi

3.9k total citations
98 papers, 2.9k citations indexed

About

Nasser Samadi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nasser Samadi has authored 98 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 20 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Nasser Samadi's work include MicroRNA in disease regulation (9 papers), RNA Interference and Gene Delivery (7 papers) and Nanoparticle-Based Drug Delivery (7 papers). Nasser Samadi is often cited by papers focused on MicroRNA in disease regulation (9 papers), RNA Interference and Gene Delivery (7 papers) and Nanoparticle-Based Drug Delivery (7 papers). Nasser Samadi collaborates with scholars based in Iran, Canada and United States. Nasser Samadi's co-authors include Simin Sharifi, Bahman Yousefi, Hamed Hamishehkar, Mehdi Sabzichi, Mohammad Saeid Hejazi, David N. Brindley, Fatemeh Ramezani, Jaleh Barar, Nosratollah Zarghami and Sepideh Zununi Vahed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Nasser Samadi

97 papers receiving 2.8k citations

Peers

Countries citing papers authored by Nasser Samadi

Since Specialization

Citations

This map shows the geographic impact of Nasser Samadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasser Samadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasser Samadi more than expected).

Fields of papers citing papers by Nasser Samadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasser Samadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasser Samadi. The network helps show where Nasser Samadi may publish in the future.

Co-authorship network of co-authors of Nasser Samadi

This figure shows the co-authorship network connecting the top 25 collaborators of Nasser Samadi. A scholar is included among the top collaborators of Nasser Samadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasser Samadi. Nasser Samadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes 2022 ·Reproductive Biology ·Saba Nikanfar, Kobra Hamdi, Sanya Haiaty, Nasser Samadi, Vahideh Shahnazi, Amir Fattahi, Mohammad Nouri	9
2	Role of adipokines in the ovarian function: Oogenesis and steroidogenesis 2021 ·The Journal of Steroid Biochemistry and Molecular Biology ·Saba Nikanfar, Hajar Oghbaei, (unknown), Reza Zarezadeh, Davoud Jafari-Gharabaghlou, Hamid Reza Nejabati, Zahra Bahrami, (unknown), Nasser Samadi, Amir Fattahi, Mohammad Nouri, Ralf Dittrich	24
3	Oxidative stress and Parkinson’s disease: conflict of oxidant-antioxidant systems 2019 ·Neuroscience Letters ·(unknown), (unknown), Mohammad Valilo, Ashkan Kalantary‐Charvadeh, Mahmood Alizadeh Sani, (unknown), Hossein Safari, Nasser Samadi	115
4	Selection of a fully human single domain antibody specific to Helicobacter pylori urease 2019 ·Applied Microbiology and Biotechnology ·(unknown), (unknown), (unknown), (unknown), Nasser Samadi, Javid Sadeghi, Jaleh Barar, Yadollah Omidi	22
5	A simple strategy for chemo-photothermal ablation of breast cancer cells by novel smart gold nanoparticles 2019 ·Photodiagnosis and Photodynamic Therapy ·(unknown), Roya Salehi, Nasser Samadi, Seyed Hossein Rasta, Behzad Mansoori, Hasan Sh. Majdi	22
6	Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles 2018 ·Pharmaceutical Research ·Vahid Shafiei‐Irannejad, Nasser Samadi, Roya Salehi, Bahman Yousefi, Mahdi Rahimi, Abolfazl Akbarzadeh, Nosratollah Zarghami	62
7	Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease 2017 ·Clinical Biochemistry ·Mohsen Hemmati-Dinarvand, (unknown), Ali Mota, Sepideh Zununi Vahed, Nasser Samadi	23
8	Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients 2016 ·Clinical Biochemistry ·Sepideh Zununi Vahed, Yadollah Omidi, Mohammadreza Ardalan, Nasser Samadi	52
9	Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells 2016 ·Molecular Biology Reports ·(unknown), Mehdi Sabzichi, Fatemeh Ramezani, Hamed Hamishehkar, Nasser Samadi	103
10	Tumor microenvironment-mediated chemoresistance in breast cancer 2016 ·The Breast ·Kobra Velaei, Nasser Samadi, (unknown), Jafar Soleimani Rad	114
11	Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery 2016 ·Current Pharmaceutical Design ·Sanam Arami, Majid Mahdavi, Mohammad‐Reza Rashidi, Marziyeh Fathi, Mohammad Saeid Hejazi, Nasser Samadi	4
12	Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment 2016 ·Colloids and Surfaces B Biointerfaces ·Mehdi Sabzichi, Nasser Samadi, Jamal Mohammadian, Hamed Hamishehkar, Maryam Akbarzadeh, Ommoleila Molavi	76
13	Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma 2015 ·Leukemia & lymphoma ·Ommoleila Molavi, Nasser Samadi, Chengsheng Wu, Afsaneh Lavasanifar, Raymond Lai	16
14	The Relation Between Thermodynamic and Structural Properties and Cellular Uptake of Peptides Containing Tryptophan and Arginine 2015 ·Advanced Pharmaceutical Bulletin ·(unknown), Javid Shahbazi Mojarrad, Samad Mussa Farkhani, (unknown), Parvin Zakeri‐Milani, Nasser Samadi, Simin Sharifi, Samaneh Mohammadi, Hadi Valizadeh	8
15	Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells 2015 ·Asian Pacific Journal of Cancer Prevention ·(unknown), (unknown), Dariush Shanehbandi, Simin Sharifi, Behzad Baradaran, Mohammad Saeid Hejazi, Nasser Samadi	38
16	Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli 2015 ·Advanced Pharmaceutical Bulletin ·(unknown), Safar Farajnia, Nosratollah Zarghami, (unknown), Nasser Samadi, (unknown), Hossein Zarei Jaliani	14
17	Combination therapy increases the efficacy of docetaxel, vinblastine and tamoxifen in cancer cells 2014 ·Journal of Cancer Research and Therapeutics ·Nasser Samadi, Parisa Ghanbari, Mahsa Mohseni, Maryam Tabasinezhad, Simin Sharifi, (unknown), Mohammad‐Reza Rashidi	44
18	Roles of the Bcl-2/Bax Ratio, Caspase-8 and 9 in Resistance of Breast Cancer Cells to Paclitaxel 2014 ·Asian Pacific Journal of Cancer Prevention ·Simin Sharifi, Jaleh Barar, Mohammad Saeid Hejazi, Nasser Samadi	92
19	Association between nucleotide mutation of eNOS gene and serum level of vessel expansion factor (VEF) in non-smoker patients with vascular heart disease 2013 ·AFRICAN JOURNAL OF BIOTECHNOLOGY ·Fatemeh Khaki‐Khatibi, Nasser Samadi, (unknown), Muhammad Sohaib Asghar, (unknown), (unknown)	1
20	Inhibition of autotaxin production or activity blocks lysophosphatidylcholine‐induced migration of human breast cancer and melanoma cells 2009 ·Molecular Carcinogenesis ·(unknown), Nasser Samadi, Jose L. Tomsig, Timothy L. Macdonald, Kevin R. Lynch, David N. Brindley	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact